BSECompany Update2 Nov 2026 · 2 Nov 2026, 08:18 pm
Reappointment of Dr. Hardik Joshipura as MD & CEO of the Company for a further term of three years commencing from February 12, 2027, to February 11, 2030, subject to approval of the shareholders of the company.
Innovassynth Technologies (India) Ltd · 533315
✦ AI SummaryMgmt Change
Innovassynth Technologies (India) Ltd has announced the reappointment of Dr. Hardik Joshipura as Managing Director & CEO for a further term of three years, subject to shareholder approval.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Innovassynth Technologies (India) Ltd - 533315 - Announcement under Regulation 30 (LODR)-Change in Directorate
Attachments (1)
📄pdf
Download →
07aaddba-6d90-4627-9942-85eb3c6706c8.pdf
View document text
Date: November 2, 2026
Manager,
Corporate Relationship Department,
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400001
Scrip Code: 533315
Subject: Intimation regarding re-appointment of Managing Director & CEO pursuant to
Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
Dear Sir/Madam,
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing
Regulations"), we wish to inform you that the Board of Directors of the Company, at its meeting
held today i.e., Monday, November 02, 2026, based on the recommendation of the Nomination
and Remuneration Committee, has considered and approved the re-appointment of Dr. Hardik
Joshipura as the Managing Director & CEO of the Company for a further term of three (3)
years commencing from February 12, 2027, to February 11, 2030 (both days inclusive), liable
to retire by rotation, on the terms and conditions recommended by the Nomination and
Remuneration Committee, subject to the approval of the shareholders of the Company.
The requisite details pursuant to Regulation 30 of the Listing Regulations read with Annexure
18 of Chapter V, Section V-A of the SEBI Master Circular dated January 30, 2026, are enclosed
herewith as Annexure A.
Kindly take the above on your records and acknowledge receipt.
Thanking You,
Yours faithfully,
For INNOVASSYNTH TECHNOLOGIES (INDIA) LIMITED
(Formerly known as Innovassynth Investments Limited)
Sameer Salim Pakhali
Company Secretary & Compliance Officer
ACS 55746
Innovassynth Technologies (India) Limited
(Formerly, Innovassynth Investments Limited)
Registered office: Corporate Office:
Old Mumbai–Pune Road, TCG International Biotech Park,
Khopoli – 410 203 India. 2nd Floor, Genesis Square,
Phone: +91–2192–260100 Hinjewadi Phase – II,
Email: itil@innovassynth.com Pune – 411 057, India.
CIN: L67120MH2008PLC178923 Phone: +91–20–61921000 www.innovassynth.com
Annexure A
1 Reasons for Change viz. Re-appointment of Dr. Hardik Joshipura as
Appointment /Re-appointment, Managing Director & CEO upon completion
resignation, removal, death or of his existing tenure.
otherwise
2 Date of appointment/re- Approved by the Board on November 02,
appointment & Term of 2026, with effect from February 12, 2027
appointment/re-appointment (both days inclusive), subject to
shareholders' approval. Re-appointed for a
further term of three (3) years commencing
February 12, 2027, to February 11, 2030.
Dr. Hardik Joshipura shall be liable to retire
by rotation.
3 Brief profile Dr. Hardik Joshipura serves as the
Managing Director & CEO of the company.
Before joining Innovassynth, he held
various senior leadership positions at
Sigma-Aldrich and later at Merck KGaA,
gaining extensive experience in
manufacturing, sales, and global strategic
marketing. Dr. Joshipura began his career
at Zydus Cadila, where he led Contract
Research R&D for the Fine Chemicals
business. He holds a Ph.D. in Organic
Chemistry and is an alumnus of Harvard
Business School (HBS), Boston, USA,
where he completed Executive MBA.
4 Disclosure of Relationships Dr. Hardik Joshipura is not related to any
between Directors Directors or Key Managerial Personnel of
the Company.
5 Other Directorships / Not applicable
Memberships (in listed entities in
case of resignation of independent
director)
6 Other details Dr. Hardik Joshipura is not debarred from
holding the office of Director by virtue of any
SEBI order or any other such authority, as
applicable.
Innovassynth Technologies (India) Limited
(Formerly, Innovassynth Investments Limited)
Registered office: Corporate Office:
Old Mumbai–Pune Road, TCG International Biotech Park,
Khopoli – 410 203 India. 2nd Floor, Genesis Square,
Phone: +91–2192–260100 Hinjewadi Phase – II,
Email: itil@innovassynth.com Pune – 411 057, India.
CIN: L67120MH2008PLC178923 Phone: +91–20–61921000 www.innovassynth.com